Senisca ^Companies

Senisca is a biotech spinout company that focuses on reversing cellular aging through the development of RNA senotherapeutics. They have identified dysregulated RNA splicing as a novel hallmark of aging and are leveraging this knowledge to develop interventions that specifically target the molecular mechanisms driving senescence. Their goal is to develop senotherapeutics that can reverse senescence and treat age-related diseases. Senisca's achievements include patent-protecting their innovation for the reversal of cellular senescence and conducting 15+ years of world-leading research in the field.